ATLS 10th Edition Instructor Course - 1.5 Days

The goal of the instructor course is to prepare doctors as instructors to teach the ATLS  student course. Over the years, the ATLS course has evolved to include greater emphasis on interactivity and small group learning. This 10th edition of the instructor course is based on the strong foundation of the previous editions, adding essentially two aspects: how to use scenario-based teaching principles and how to facilitate student learning, moving away from "sage on the stage" and embracing the role of "guide on the side." 

This course is a team-teaching interactive learning experience with the course director, an ATLS educator, and experienced ATLS instructors. In this experience, the course participants will acquire an understanding of the of the adult education principles that are used in the design and delivery of ATLS learning and teaching. Course participants are then provided an opportunity to put them into practice using the principles during practice training sessions. This structured team-teaching experience employs the newest concepts of adult education to optimally prepare new instructors for their roles as teacher, facilitator, instructor, and mentor of an ATLS student course. The approach of the instructor course is closely aligned with the pedagogy used in the 10th edition ATLS student course. 

Contact

For questions about course content, please contact the ATLS office at atls@facs.org or 312-202-5160.

Target Audience

  • Student Course participants identified as having instructor potential may advance to the Instructor Course within a specified time frame
  • Teaches the doctor how to teach the Advanced Trauma Life Support® (ATLS®) Student Course
  • Eligibility to participate is limited to doctors in countries where the program has been introduced and promulgated by the ACS

Learning Objectives

  • Discuss the mission of the ATLS Instructor
  • Describe what concepts the instructor course teaches and what participants will learn
  • Recognize specific requirements for successful instructor course completion
Course summary
Available credit: 
  • 12.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Completion
Course opens: 
12/05/2016
Course expires: 
12/26/2024

Course Faculty and Disclosures

Karen Brasel, MD, FACS
No disclosures

Sharon Henry, MD, FACS
No disclosures

Disclosure Policy

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest. Therefore, it is mandatory that both the program planning committee and speakers complete disclosure forms. Members of the program committee were required to disclose all financial relationships and speakers were required to disclose any financial relationship as it pertains to the content of the presentations. The ACCME defines a 'commercial interest' as "any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients." It does not consider providers of clinical service directly to patients to be commercial interests. The ACCME considers "relevant" financial relationships as financial transactions (in any amount) that may create a conflict of interest and occur within the 12 months preceding the time that the individual is being asked to assume a role controlling content of the educational activity.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the session. The planning committee members and speakers were contacted and the conflicts listed below have been managed to our satisfaction. However, if you perceive a bias during a session, please advise us of the circumstances on the session evaluation form.

Please note we have advised the speakers that it is their responsibility to disclose at the start of their presentation if they will be describing the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug or unapproved usage.

The requirement for disclosure is not intended to imply any impropriety of such relationships, but simply to identify such relationships through full disclosure, and to allow the audience to form its own judgments regarding the presentation.

Available Credit

  • 12.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Completion
Please login or register to take this course.